Elevance Health Inc. cash flow to debt ratio of 12.91% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Elevance Health Inc.'s free cash flow has decreased 30.27% from $4.55B last year to $3.17B, signaling decreasing performance

Elevance Health Inc.'s debt to equity ratio is 0.69, which means that the company's assets are unhealthy financed, signaling financial risk.

Elevance Health Inc.'s debt has decreased relative to shareholder equity from 0.79 last year to 0.69 today, signaling strengthened financials

Elevance Health Inc. has a net debt to EBITDA ratio of 2.46x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Elevance Health Inc.'s interest coverage ratio of 6.25 indicates that earnings with good margin can cover interest payments on company debt

Elevance Health Inc.'s profit margin has decreased (27.03%) in the last year from 3.38% to 2.47%, signaling decreasing performance

Elevance Health Inc.'s short-term assets of $24.73B exceed its short-term liabilities of $19.96B

Elevance Health Inc.'s return on assets of 3.93% is lower than the 5.00% threshold, indicating inefficient asset utilization

Elevance Health Inc.'s return on equity of 11.24%, is lower than 15.00%, indicating bad performance

Elevance Health Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Elevance Health Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Elevance Health Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Elevance Health Inc. has a free cash flow yield of 3.68%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Elevance Health Inc.'s yearly earnings has decreased 5.32% since last year from $5.98B to $5.66B, signaling decreasing performance

Elevance Health Inc.'s yearly revenue has increased 12.37% since last year from $176.81B to $198.69B, signaling increasing performance

ROIC 7.22% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Elevance Health Inc.'s 3-year revenue CAGR of 8.34% is positive, indicating growing revenue over the past 3 years

Elevance Health Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Elevance Health Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Elevance Health Inc. has insufficient data to evaluate this check.

Elevance Health Inc. has an earnings yield of 5.73%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Elevance Health Inc. is overvalued relative to its fair value price of 198.74 based on EBITDA multiple model

Elevance Health Inc. has an EV/EBITDA ratio of 11.39x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Elevance Health Inc. is undervalued relative to its fair value price of 895.20 based on Earnings Fair Value model

Elevance Health Inc. has a PEG-ratio over 1 which is considered overvalued

Elevance Health Inc. has a price-to-book ratio of 1.92x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Elevance Health Inc. has a price-to-sales ratio of 0.43x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue